Effect of a ketogenic diet on decrease of seizures in refractory epilepsy among children (infancy to 14 years old) in

Leena R Baghdadi1, Renad A Alhomaidi2, Fatimah S Alhelal2

  • 1Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Translational Pediatrics
|October 10, 2023
PubMed

Insights

Ketogenic diets show promise for treating refractory epilepsy in children. Higher diet ratios (3:1, 4.5:1) and physical activity improved seizure frequency, while parental education and income also influenced outcomes.

Area of Science:

  • Pediatric Neurology
  • Metabolic Therapies
  • Epilepsy Management

Background:

  • Refractory epilepsy in children is defined by persistent disabling seizures despite anti-seizure drug trials.
  • Ketogenic diets are an established treatment for refractory seizures globally, but underutilized in Saudi Arabia.
  • This study investigates ketogenic diet efficacy and influencing factors in Saudi children with refractory epilepsy.

Purpose of the Study:

  • To examine the relationship between ketogenic diet exposure and seizure frequency reduction in pediatric refractory epilepsy.
  • To identify factors associated with improved seizure outcomes in children on ketogenic diets.
  • To assess the impact of diet ratios, physical activity, and sociodemographic factors on seizure control.

Main Methods:

  • A cross-sectional study was conducted at King Fahad Medical City, Riyadh, Saudi Arabia.
  • Medical records of 95 children (10 months to 14 years) with refractory epilepsy on ketogenic diets were reviewed.
  • Parental socioeconomic data were collected via phone interviews.

Main Results:

  • Children on higher ratio ketogenic diets (3:1 and 4.5:1) experienced decreased seizure frequency (up to 44%).
  • Patients with generalized epilepsy (56.1%) and ambulatory patients (66.7%) showed the most significant seizure outcome improvements.
  • Lower seizure improvement was linked to lower parental education, lower income, and later age of seizure diagnosis (>8 years).

Conclusions:

  • Ketogenic diets are a viable and promising treatment for pediatric refractory epilepsy.
  • Higher ketogenic diet ratios and increased physical activity correlate with better seizure control.
  • Parental education, income, and patient mobility are significant factors influencing treatment success.
Abstract

Related Concept Videos

Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
614
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
318
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
194
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
420
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
192
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
426